Cancer induction by restriction of oncogene expression to the stem cell compartment
about
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activationEvaluating biomarkers to model cancer risk post cosmic ray exposureCould Vitamin D Analogues Be Used to Target Leukemia Stem Cells?The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem CellsIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachGlioblastoma cancer stem cells: Biomarker and therapeutic advancesIn vitro models of cancer stem cells and clinical applicationsTargeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia.Increased epithelial stem cell traits in advanced endometrial endometrioid carcinoma.Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma.Bcl2 is not required for the development and maintenance of leukemia stem cells in mice.Constitutive Stat3 activation alters behavior of hair follicle stem and progenitor cell populationsRadiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors.The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues.Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling.Acute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo.In vitro generation of human cells with cancer stem cell properties.Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectivesThe crossroads between cancer stem cells and aging.Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.Stem cell antigen-1 deficiency enhances the chemopreventive effect of peroxisome proliferator-activated receptorγ activation.Design and Characterization of Bioengineered Cancer-Like Stem Cells.Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice.Diverging fates of cells of origin in acute and chronic leukaemia.Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB.The cancer stem cell paradigm: a new understanding of tumor development and treatment.Characterization of the stem cell niche and its importance in radiobiological response.Genetic background affects susceptibility to tumoral stem cell reprogramming.Radiation responses of cancer stem cells.Stem cells and cancer of the stomach and intestine.Chronic myeloid leukemia stem cells and developing therapies.Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.Mouse models as tools to understand and study BCR-ABL1 diseases.Myeloproliferative neoplasm animal modelsFunction of oncogenes in cancer development: a changing paradigm.Concise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure for more effective targeting.
P2860
Q24307782-32EC2034-3845-492C-A4BC-83AEC3CD7C2DQ26747120-83683AF0-95DB-42D8-AA1F-273253EB7896Q26747513-5B7B2372-AA85-460B-ACE5-97E6B25C5B25Q26765892-35FE55F0-3818-44EC-B226-EC4619206F4BQ26779702-4C8F6061-7D9D-4A23-A665-1DBE5A56A78BQ26849477-334B1796-F02B-4C24-86DE-22FBECA8C540Q26859782-22EB445D-3AEB-47AB-B268-F9F62BDB7D4DQ28076101-11810B94-2C5C-4C02-AE5A-7531771EB223Q30010486-C5E3B12C-81A7-47F6-91A5-EAA4D9FD6A87Q33518922-8AD916D2-950B-4D7C-88FB-D999F0029CCAQ33642194-B9E68205-8FB2-466C-BE3B-4F178F52A780Q33947776-854A8046-CD3A-48A2-8CD4-9D6A8C7E2D7CQ34071276-66B9CBDE-B693-4B5A-9A17-F5356A29573DQ34131280-4261768D-2AE7-4E51-ABFA-F32CB2EF2A28Q34218232-BE30898E-A684-4779-87B3-CA31E858722CQ34383712-E6E03BAA-7816-47A8-B60E-B7C4920269FEQ34750582-18C63E5C-AAE5-4153-BC9D-9D5C879D80F8Q34977982-205AFAC7-70FB-4ABD-8E6E-35730F45362EQ35106493-DC759A00-CBC6-4D5D-A56A-D75994F36D99Q35196349-993BAC23-0D1D-4FEC-9A8D-1D0163F961B1Q35485571-2E14D689-721F-49B6-B40F-E30CF4B8DAD4Q35566484-79185308-941B-458B-85DA-4278D6CBB9F1Q35640320-8573C236-351F-46E4-BC47-BE164284B401Q35656198-B0B53634-C27D-43CE-8DF3-B9B35AEA5E59Q35815783-D72C2D16-8CFF-4F30-B088-B8904964547AQ35987068-12C7E9A6-8677-475E-8587-3FA61324507AQ36038002-75289F9F-E64D-42A9-A0EE-B6F5B3AD3169Q36068948-8FE7BFD6-AA14-483C-9AF4-4AD3F6CD6CE5Q36392184-D4DB8CBD-6B46-40C5-90F5-E0E215A0A42FQ36854372-1A30ABAD-AB52-497E-81F8-2F74B3AD7673Q37158304-08863FBD-A42B-42A6-BBB2-08313A515CE7Q37344811-BCA66A9C-82F9-4B03-81E7-26AEE3E620F3Q37558374-27D8D036-E7E8-4225-A6FA-95A706A92952Q37769649-4A1DBC13-289D-4175-A485-C9773A407FEEQ37836936-C622972F-7BFA-47CF-A08D-87E21F984957Q37978771-695EDECB-719D-4F91-90BF-1E8789A6CF5FQ37995194-E276C9BF-28F8-434F-85E4-25093DDA4D2AQ38046320-5D9D6DA4-0A73-4810-80F7-CF0EEEC9A9E9Q38103175-E4120761-07F2-4A1F-8B74-0A1DB0B8E9DAQ38187388-F0BAC23D-387B-4BBF-B7AF-43BF1348196A
P2860
Cancer induction by restriction of oncogene expression to the stem cell compartment
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Cancer induction by restriction of oncogene expression to the stem cell compartment
@en
Cancer induction by restriction of oncogene expression to the stem cell compartment.
@nl
type
label
Cancer induction by restriction of oncogene expression to the stem cell compartment
@en
Cancer induction by restriction of oncogene expression to the stem cell compartment.
@nl
prefLabel
Cancer induction by restriction of oncogene expression to the stem cell compartment
@en
Cancer induction by restriction of oncogene expression to the stem cell compartment.
@nl
P2093
P2860
P50
P356
P1433
P1476
Cancer induction by restriction of oncogene expression to the stem cell compartment
@en
P2093
Alberto Orfao
Camino Bermejo-Rodríguez
Inés González-Herrero
Isidro Sánchez-García
Manuel Sánchez-Martín
Margarita Sánchez-Beato
María Pérez-Caro
Rafael Jiménez
Teresa Flores
P2860
P356
10.1038/EMBOJ.2008.253
P407
P577
2008-11-27T00:00:00Z